Premium
Development and validation of a liquid chromatography/tandem mass spectrometry method to quantify metabolites of phthalates, including di‐2‐ethylhexyl terephthalate (DEHTP) and bisphenol A, in human urine
Author(s) -
Frigerio Gianfranco,
Campo Laura,
Mercadante Rosa,
Santos Patricia Martín,
Missineo Pasquale,
Polledri Elisa,
Fustii Silvia
Publication year - 2020
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.8796
Subject(s) - chemistry , phthalate , chromatography , bisphenol a , urine , tandem mass spectrometry , mass spectrometry , isotope dilution , liquid chromatography–mass spectrometry , bisphenol , organic chemistry , biochemistry , epoxy
Rationale Several phthalates and bisphenol A are endocrine‐disrupting chemicals (EDCs). Recently, their use has been partially restricted and less toxic compounds, such as di‐2‐ethylhexyl terephthalate (DEHTP), have been placed on the market. The aim of this work was to develop and validate a method for the simultaneous quantitation of bisphenol A and urinary metabolites of phthalates, including DEHTP. Methods An isotopic dilution high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC/ESI‐MS/MS) method for the determination of bisphenol A (BPA), monobenzyl phthalate (MBzP), mono‐2‐ethyl‐5‐carboxypentyl phthalate (MECPP), mono‐2‐ethyl‐5‐carboxypentyl terephthalate (MECPTP), mono‐2‐ethyl‐5‐hydroxyhexyl terephthalate (MEHHTP), monoethyl phthalate (MEP), and mono‐n/i‐butyl phthalates (MnBP/MiBP) in human urine was developed. A complete validation was carried out and the method was applied to 36 non‐occupationally exposed adults. Results Limits of quantitation ranged from 0.02 (MECPP) to 1 μg/L (MnBP and MiBP). Relative standard deviations below 10% indicated a suitable precision; accuracy, evaluated using a standard reference material, ranged from 74.3% to 117.5%; isotopically labelled internal standards were suitable for correcting the matrix effect. The accuracy was confirmed by the successful participation in an external verification exercise. However, for terephthalates, the validation was incomplete due to the lack of reference materials and external verification. Levels of the investigated chemicals in subjects were in line with those previously reported. Conclusions An LC/MS/MS assay for the simultaneous measurement of BPA and phthalate metabolites in human urine was developed and validated; it is useful to investigate exposure in epidemiological studies involving the general population.